The ABC Of Innovation And Why “The F Word” Should Not Offend

Organizations need to adopt a “disruption mind-set,” whatever kind of innovation they are pursuing, and the most successful innovators realize that innovation is not just the province of the R&D department but the whole company. So say executives at PA Consulting, whose recent report, "Innovation As Unusual," highlights the importance of the “Innovation Leader” role, and has useful advice for life science and health care innovators.

Does your organization have an Innovation Leader? Leadership is the most important element in setting and fulfilling the business plan. “If you have people who have a passion for innovation and can lead, that is 80% of the battle won.” That is the view of Ian Rhodes, the CEO of McLaren Applied Technologies (design, technology and simulation solutions for diverse industries). He was interviewed as part of a report by consulting, technology and innovation firm, PA Consulting.

The report, “Innovation As Unusual,” surveyed 751 executives. It takes a UK-biased view of a global theme –...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Innovation

More from In Vivo

Podcast: Acuitas CSO On CRISPR Delivery Breakthrough And Next-Gen Lipid Nanoparticle Technology

 
• By 

In Vivo sits down with Ying Tam, CSO at Acuitas Therapeutics, to discuss the company's role in delivering the first personalized CRISPR treatment to an infant and the clinical implications of new lipid nanoparticle technologies.

BioBytes: AI-Related Deals In Q2 ‘25

 
• By 

When it came to AI-related deals, the second quarter of 2025 was characterized by mostly modest financings.

Titans Of Pharma: Lilly’s Ricks Tops Big Pharma Pay Chart

 

The big pharma CEO with the highest-valued compensation in 2024 was David Ricks of Eli Lilly, while Pfizer and J&J executives slipped into third and fourth place behind AbbVie's now retired chief Richard Gonzalez. European firms brought up the rear.